Summit Therapeutics Inc. (SMMT)
19.09
-1.60 (-7.73%)
At close: Mar 03, 2025, 3:59 PM
19.29
1.02%
Pre-market: Mar 04, 2025, 04:32 AM EST
Summit Therapeutics Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 |
| Revenue | n/a | n/a | 704.29K | 1.81M | 860K | 632.02K | 56.41M | 35.98M | 2.88M | n/a | 2.27M | 2.27M | 2.87M | 2.77M | 1.21M | 301.94K | 266.64K | 6.03M | 2.03M | 947.89K | 212.76K | 1.82K |
| Cost of Revenue | 15.01M | 2.05M | 2.51M | n/a | n/a | 155.4K | 24.92K | 97.67K | n/a | n/a | n/a | n/a | n/a | 1.01M | n/a | n/a | 5.77K | 2.51M | 596.3K | 415.93K | 169.46K | 1.82K |
| Gross Profit | -15.01M | -2.05M | -1.81M | 1.81M | 860K | 476.62K | 56.39M | 35.88M | 2.88M | n/a | 2.27M | 2.27M | 2.87M | 1.76M | 1.21M | 301.94K | 260.87K | 3.51M | 1.43M | 531.96K | 43.3K | n/a |
| Operating Income | 313K | -89.74M | -72.09M | -86.19M | -53.19M | -42.76M | 12.38M | -18.25M | -31.07M | -28.73M | -19.15M | -11.07M | -7.23M | -4.71M | -9.38M | -9.2M | -19.2M | -23.4M | -8.6M | -3.21M | -536.61K | -43.79K |
| Interest Income | n/a | 10.4M | 1.51M | 178.95K | 4K | 4.34K | 3.66M | 4.38M | 10K | 30K | n/a | 14.85K | 17.37K | 10.99K | 26.9K | 12.78K | 430.95K | 1.54M | 1.72M | 1.04M | 404.81K | 1.82K |
| Pretax Income | -221.31M | -615.87M | -78.78M | -88.6M | -52.91M | -28.41M | 6.6M | -15.42M | -32.13M | -28.69M | -19.07M | -11.05M | -7.21M | -4.71M | -9.36M | -9.3M | -18.88M | -21.94M | -6.88M | -2.17M | -131.8K | -41.96K |
| Net Income | -221.31M | -614.93M | -74.38M | -86.15M | -52.7M | -23.88M | 9.87M | -10.09M | -26.71M | -24.34M | -17.12M | -10.05M | -6.67M | -4.23M | -7.42M | -8.66M | -32.29M | -20.13M | -5.92M | -1.89M | -86.61K | -41.96K |
| Selling & General & Admin | 60.53M | 28.21M | 26.7M | 23.61M | 19.23M | 9.3M | 16.19M | 16.98M | 10.35M | 7.45M | 6.8M | 3.24M | 2.77M | 2.31M | 2.68M | 4.2M | 5.03M | 7.31M | 1.86M | 1.79M | 75.31K | 43.79K |
| Research & Development | 150.78M | 59.47M | 52M | 85.35M | 53.27M | 32.71M | 51.38M | 41.01M | 23.69M | 23.94M | 15.64M | 10.83M | 5.72M | 4.78M | 3.66M | 3.68M | 7.38M | 15.34M | 5.79M | 1.83M | 504.6K | n/a |
| Other Expenses | n/a | n/a | -14.42M | -20.97M | -19.31M | n/a | -19.88M | -3.86M | -1.95M | -3.14M | -682.9K | -682.9K | 18.95K | 339.19K | -10.32M | 3.48M | 2.97M | 2.7M | 2.37M | 119.6K | n/a | -1.82K |
| Operating Expenses | 211.3M | 87.69M | 64.28M | 88M | 53.19M | 42M | 47.69M | 54.13M | 33.94M | 29.45M | 19.29M | 13.33M | 8.51M | 7.45M | 5.55M | 9.49M | 15.43M | 26.92M | 10.03M | 3.74M | 579.92K | 43.79K |
| Interest Expense | -8.69M | 16.46M | 4.4M | 281K | 255K | 32.52K | 556.1K | 1.65M | 1.08M | n/a | 448K | n/a | n/a | 4.71K | 6.33K | 107.04K | 116.74K | 75.56K | 11.77K | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | -2.05M | n/a | n/a | n/a | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 372.24K | 1.12M | 2.17M | 1M | n/a | n/a | n/a |
| Cost & Expenses | 226.31M | 89.74M | 64.28M | 88M | 53.19M | 43.4M | 47.69M | 54.13M | 33.94M | 29.45M | 19.29M | 13.33M | 8.51M | 7.45M | 5.55M | 9.49M | 15.43M | 29.43M | 10.62M | 4.16M | 749.37K | 45.61K |
| Income Tax | n/a | -946K | -4.4M | -2.46M | -213K | -4.52M | -3.27M | -5.32M | -5.42M | -4.36M | -1.95M | -1M | -538.61K | -477.37K | -1.94M | -594.31K | -2.52M | -1.81M | -959.18K | -278.48K | -45.19K | -1.82K |
| Shares Outstanding (Basic) | 718.54M | 619.65M | 193.34M | 92.24M | 69.52M | 164.15M | 86.14M | 65.03M | 61.55M | 59.1M | 39.6M | 4.83M | 15.81M | 177.88M | 166.29M | 67.01M | 53.39M | 47.9M | 36.42M | 31.31M | 23.46M | 19.02M |
| Shares Outstanding (Diluted) | 718.54M | 619.65M | 193.34M | 92.24M | 69.52M | 164.15M | 86.14M | 65.43M | 61.55M | 59.1M | 39.6M | 4.83M | 15.81M | 177.88M | 166.29M | 67.01M | 53.39M | 47.9M | 36.42M | 31.31M | 23.46M | 19.02M |
| EPS (Basic) | -0.31 | -0.99 | -0.38 | -0.93 | -0.76 | -0.15 | 0.11 | -0.16 | -0.43 | -0.41 | -0.43 | -2.08 | -0.42 | -0.02 | -0.04 | -0.13 | -0.6 | -0.42 | -0.16 | -0.06 | -0.00 | -0.00 |
| EPS (Diluted) | -0.31 | -0.99 | -0.38 | -0.93 | -0.76 | -0.15 | 0.11 | -0.15 | -0.43 | -0.41 | -0.43 | -2.08 | -0.42 | -0.02 | -0.04 | -0.13 | -0.6 | -0.42 | -0.16 | -0.06 | -0.00 | -0.00 |
| EBITDA | 313K | 1M | -52.63M | -62.74M | -37.13M | -16.8M | 11.65M | -32.19M | -30.98M | -20.3M | -12.2M | -11.02M | -5.48M | -4.41M | -8.65M | -5.41M | -16.03M | -18.58M | -6.13M | -2.97M | -527.2K | -41.96K |
| Depreciation & Amortization | n/a | 90.74M | 2.51M | 2.46M | 2M | 1.39M | 1.49M | 348.2K | 72.5K | 68.36K | 49.72K | 42.89K | 146.89K | 295.22K | 710.54K | 3.78M | 2.74M | 3.28M | 737.53K | 240.99K | 9.41K | 1.82K |